#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pouchitis Biotinidase deficiency Anti-HLA antibody test positive Penile cancer Breast cancer metastatic Colitis ulcerative Osteochondrodysplasia Ehlers-Danlos syndrome Dementia with Lewy bodies Cholangiocarcinoma Infertility male Kaposi's sarcoma Multiple system atrophy Systemic scleroderma Ovarian cancer stage IV More trials…

    Learn about Rare Diseases

    Haemophagocytic lymphohistiocytosis – Trials in Disease Glomerulonephritis rapidly progressive – Basic Information Tuberous sclerosis complex Myxofibrosarcoma – Diagnostics Breast angiosarcoma metastatic Marginal zone lymphoma – Life with Disease Tuberous sclerosis complex – Diagnostics Breast angiosarcoma metastatic – Diagnostics Stevens-Johnson syndrome – Diagnostics Osteosarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Enalapril Maleate Zetomipzomib At-1501 Fipaxalparant Phentermine RNMB2 Fluocinolone Acetonide Bi 3032950 Blu-451 Trientine Dihydrochloride Infliximab Calcium Pantothenate Bp [Al[18F]F]Fapi-74 Viltolarsen LUNSEKIMIG Tuvusertib Zanamivir Dexamfetamine Sulfate Trimethoprim Zalunfiban More therapies…

    Learn about Your Condition

    White matter lesion Hairy cell leukaemia Non-obstructive cardiomyopathy Colon cancer stage II Bile duct adenocarcinoma Pulmonary sarcoidosis Dry mouth Arthroscopy Spina bifida Mitral valve incompetence Thymoma Post-acute COVID-19 syndrome Rhabdomyosarcoma Noninfective chorioretinitis Osteosarcoma metastatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hepatic fibrosis

  • Study on Simvastatin for Reducing Liver Fibrosis in Patients with Advanced Alcohol-Related Liver Disease

    Recruiting

    4 1 1
    Investigated Diseases:
    • Hepatic fibrosis
    • Liver disorder
    • Alcoholic liver disease
    Investigated Drugs:
    • Simvastatin
    Spain

  • Study on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis

    Recruiting

    3 1
    Investigated Diseases:
    • Hepatic fibrosis
    Investigated Drugs:
    • Efruxifermin
    France Germany Italy Poland Spain

  • Study on the Effects and Safety of Nicotinamide for Patients with Type 2 Diabetes and Liver Fibrosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatic fibrosis
    Investigated Drugs:
    • Nicotinamide
    Spain

  • Study on the Effects of a Mediterranean Diet with Intermittent Fasting vs. Bupropion and Naltrexone in Overweight Patients with Type 2 Diabetes and Liver Fibrosis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatic fibrosis
    Investigated Drugs:
    • Bupropion Hydrochloride
    • Naltrexone Hydrochloride
    The Netherlands

  • Study comparing how the body processes GB1211 capsule and tablet forms with and without food in healthy volunteers

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Hepatic fibrosis
    • Non-small cell lung cancer
    Investigated Drugs:
    • 2-(5-BROMOPYRIDIN-3-YL)SULFANYL-6-(HYDROXYMETHYL)-4-[4-(3,4,5-TRIFLUOROPHENYL)TRIAZOL-1-YL]OXANE-3,5-DIOL
    • 5-Bromopyridin-3-Yl 3-Deoxy-1-Thio-3-[4-(3,4,5-Trifluorophenyl)-1H-1,2,3-Triazol-1-Yl]-Alfa-D-Galactopyranoside
    The Netherlands

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!